DNA Plc: Managers' transactions: Timo Karppinen


DNA PLC MANAGERS' TRANSACTIONS 3 October, 2019 3:00 pm EEST

DNA has received a notification from Timo Karppinen, Chief Financial Officer, of a transaction made with DNA’s financial instrument, according to the EU Market Abuse Regulation. Detailed information about the transaction is given here under.
____________________________________________

Person subject to the notification requirement

Name:                                  Timo Karppinen
Position:                              Chief Financial Officer

Issuer:                                  DNA Plc
LEI:                                      7437003Y73DAKAXYJV21

Notification type:                  Initial notification
Reference number:              7437003Y73DAKAXYJV21_20191002114531_3
____________________________________________

Transaction date:                  2 October 2019
Venue:                                  NASDAQ Helsinki Ltd (XHEL)
Instrument type:                   share
ISIN:                                     FI4000062385
Nature of the transaction:     Disposal

Transaction details
(1): Volume: 21,260 Unit price: 20.90 EUR

Aggregated transactions
(1): Volume: 21,260 Volume weighted average price: 20.90 EUR

Total ownership of DNA’s shares of Timo Karppinen after the transaction: 0 shares.

Further enquiries:
Marja Mäkinen, Head of Investor relations, DNA Plc, tel. +358 44 044 1262, marja.makinen@dna.fi
DNA Corporate Communications, tel. +358 44 044 8000, communications@dna.fi

DNA is one of the leading telecommunications companies in Finland. We want to make our customers' daily lives less complicated. We offer connections, services and devices for homes and workplaces, contributing to the digitalisation of society. DNA’s mobile communication network customers have the highest mobile data usage per subscription in the world. We are also Finland's largest cable TV operator and the leading pay-TV provider. DNA has more than 4 million subscriptions in its fixed and mobile communications networks. The company was ranked the best employer in Finland in the large companies category of the 2019 Great Place to Work survey. In 2018, our net sales were EUR 912 million and we employ about 1,600 people around Finland. DNA shares are listed on Nasdaq Helsinki Ltd. More information: www.dna.fi, Twitter @DNA_fi and Facebook.